Related by context. Frequent words. (Click for all words.) 86 REOLYSIN R 57 AP# [003] 57 MGCD# [002] 56 Phase Ib 56 randomized Phase 56 voreloxin 55 FOLOTYN 55 T DM1 54 nimotuzumab 54 ERBITUX 54 perifosine 54 XL# [003] 54 IMGN# 54 picoplatin 53 Phase 1b 53 MGCD# [001] 53 docetaxel 53 ADVEXIN 53 ASA# 53 CUDC 52 oncology indications 52 carboplatin 52 solid tumors 52 ANA# 52 dose escalation 52 AEOL # 51 metastatic melanoma 51 hematological malignancies 51 gemcitabine 51 RG# [001] 51 satraplatin 51 bavituximab 51 Multikine 51 Phase 2a 51 INCB# [002] 51 CYT# 50 ABRAXANE 50 HspE7 50 MDV# 50 Genasense 50 pivotal Phase 50 Stimuvax 50 Zevalin 50 cytarabine 50 tivozanib 49 panitumumab 49 pixantrone 49 carfilzomib 49 Phase III clinical 49 Phase IIb clinical 49 Marqibo 49 ispinesib 49 reovirus 49 Phase 2b clinical 48 Nexavar 48 anticancer agents 48 elesclomol 48 ENMD 48 rituximab 48 ZEVALIN 48 ofatumumab 48 APF# 48 BiovaxID 48 Oncophage 48 Phase 2b 48 Phase IIa clinical 48 antitumor activity 48 pivotal Phase III 47 hematologic malignancies 47 Phase 2b trial 47 chemotherapeutic agents 47 temozolomide 47 CBLB# 47 Locteron 47 Prochymal 47 Phase 2b study 46 cancer immunotherapy 46 RAD# [003] 46 preclinical studies 46 Tovaxin 46 immunotherapeutic 46 PROVENGE 46 Oncolytics 46 orBec R 45 gefitinib 45 Vidaza 45 VELCADE 45 ISIS # 45 orBec ® 45 RNAi therapeutic 45 APD# 44 AZD# 44 Dacogen 43 Tekmira 43 PRX # 43 ISA# [002] 42 SPRYCEL 42 ALIMTA 41 Hollis Eden 40 Oncolytics Biotech Inc. 36 RNAi therapeutics